Thursday, November 12, 2026||
MultiKhabarMultiKhabar

Miro clears TGA audit ahead of Crohn’s disease trial

TH
The Age Australia
By Murray Ward
Share:WhatsAppFacebookX (Twitter)Telegram
Miro clears TGA audit ahead of Crohn’s disease trial
Photo / Coverage: The Age AustraliaCredit: Murray Ward
EXECUTIVE SUMMARY

Miro Sciences has cleared a TGA manufacturing hurdle for its Crohn’s trial, with the regulator inspecting its partner’s facility ahead of a planned Phase 2 study for its StemSmart cell therapy.

Key Takeaways

  • Miro clears TGA audit ahead of Crohn’s disease trial.
  • Miro Sciences has cleared a TGA manufacturing hurdle for its Crohn’s trial, with the regulator inspecting its partner’s facility ahead of a planned Phase 2 study for its StemSmart cell therapy.
  • Miro Sciences has cleared a TGA manufacturing hurdle for its Crohn’s trial, with the regulator inspecting its partner’s facility ahead of a planned Phase 2 study for its StemSmart cell therapy.

Miro Sciences has cleared a TGA manufacturing hurdle for its Crohn’s trial, with the regulator inspecting its partner’s facility ahead of a planned Phase 2 study for its StemSmart cell therapy.

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on The Age Australia

Visit Publisher Site →
OTHER MEDIA SOURCES COVERING THIS STORY
2 Publishers Reporting
Sydney Morning Herald
Miro clears TGA audit ahead of Crohn’s disease trial

Related News

🇦🇺 Australia
Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play